Update in General Internal Medicine
Authors: John V.L. Sheffield, Eric B. Larson
Journal: Annals of Internal Medicine (2005)

Updates2 August 2005Update in General Internal MedicineJohn V.L. Sheffield, MD and Eric B. Larson, MD, MPHJohn V.L. Sheffield, MDFrom Harborview Medical Center and Group Health Cooperative, Seattle, Washington.Search for more papers by this author and Eric B. Larson, MD, MPHFrom Harborview Medical Center and Group Health Cooperative, Seattle, Washington.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-143-3-200508020-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Our goal for this Update in General Internal Medicine is to update practicing internists on the past year's clinically important research papers. We compiled these articles with the help of general internists and subspecialists from the University of Washington, along with the editors of ACP Journal Club.Cardiovascular Disease and Statin UseThis year's trial results indicate a real change in our understanding of indications for the use of statins. In type 2 diabetic patients with at least 1 additional risk factor for coronary heart disease, lipid-lowering treatment with statins is effective for primary prevention of cardiovascular disease (CVD). In ...References1. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39. [PMID: 15249516] CrossrefMedlineGoogle Scholar2. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53. [PMID: 15632335] CrossrefMedlineGoogle Scholar3. Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case–control study. Lancet. 2005;365:475-81. [PMID: 15705456] CrossrefMedlineGoogle Scholar4. Furberg CD, Psaty BM, FitzGerald GA. Parecoxib, valdecoxib, and cardiovascular risk [Editorial]. Circulation. 2005;111:249. [PMID: 15655125] CrossrefMedlineGoogle Scholar5. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291:2947-58. [PMID: 15213206] CrossrefMedlineGoogle Scholar6. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291:2959-68. [PMID: 15213207] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Harborview Medical Center and Group Health Cooperative, Seattle, Washington.Disclosures: None disclosed.Corresponding Author: Eric B. Larson, MD, MPH, Group Health Cooperative, Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101-1448.Current Author Addresses: Dr. Sheffield: Harborview Medical Center, Box 359782, 325 Ninth Avenue, Seattle, WA 98104.Dr. Larson: Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101-1448. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 2 August 2005Volume 143, Issue 3Page: 212-221KeywordsBlood pressureCholesterolDietExerciseHypertensionProstate cancerRevascularizationStable coronary artery diseaseVaccines ePublished: 2 August 2005 Issue Published: 2 August 2005 CopyrightCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...